{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:16Z","timestamp":1792204996410,"version":"4.4.0"},"reference-count":45,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The HBV rtA181T mutation is associated with an increased risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). This study aimed to evaluate the mechanism by which rtA181T mutation increases the risk of HCC. We enrolled 470 CHB patients with rtA181T and rtA181V mutation in this study; 68 (22.15%) of the 307 patients with rtA181T mutation and 22 (13.5%) of the 163 patients with rtA181V mutation developed HCC (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u2009.05). The median follow\u2010up periods were 8.148 and 8.055\u2009years (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&gt;\u2009.05). Serum HBV DNA and HBsAg levels in rtA181T\u2010positive patients were similar to that in rtA181V\u2010positive patients. However, the serum HBeAg levels in the rtA181T\u2010positive patients were significantly higher than that in rtA181V\u2010positive patients. In situ hybridization experiments showed that the HBV cccDNA and HBV RNA levels were significantly higher in the liver cancer tissues of patients with the rtA181T mutation compared to that in the tissues of patients with the rtA181V mutation. The percentage of anti\u2010tumour hot\u2010gene site mutations was significantly higher in the rtA181T\u2010positive HCC liver tissue compared to that in the rtA181T\u2010negative HCC liver tissue (7.65% and 4.3%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u2009.05). This is the first study to use a large cohort and a follow\u2010up of more than 5\u2009years (average 8\u2009years) to confirm that the rtA181T mutation increased the risk of HCC, and that it could be related to the increase in the mutation rate of hotspots of tumour suppressor genes (CTNNB1, TP53, NRAS and PIK3CA).\n                  <\/jats:p>","DOI":"10.1111\/jvh.13886","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:44:57Z","timestamp":1695343497000},"page":"951-958","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":195,"title":["<scp>CHB<\/scp>\n                    patients with\n                    <scp>rtA181T<\/scp>\n                    \u2010mutated\n                    <scp>HBV<\/scp>\n                    infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes"],"prefix":"10.1111","volume":"30","author":[{"given":"Qiqi","family":"Ning","sequence":"first","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongwang","family":"Yang","sequence":"additional","affiliation":[{"name":"Academician Workstation Changsha Medical University  Changsha China"},{"name":"Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations Changsha Medical University  Changsha China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Guo","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiang","family":"Huang","sequence":"additional","affiliation":[{"name":"Clinical laboratory center, Beijing You An Hospital, Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengcheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxiang","family":"Yang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyue","family":"Guan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6896-6640","authenticated-orcid":false,"given":"Dexi","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing Institute of Hepatology, Beijing You An Hospital, Capital Medical University  Beijing China"},{"name":"Beijing Precision Medicine and Transformation Engineering Technology Research Center of Hepatitis and Liver Cancer  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"issue":"9","key":"e_1_2_12_2_1","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival","volume":"109","author":"Ahmedin J","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2013.243"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60220-8"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-S4-05"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2014.909724"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28280"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22295"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26301"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.03.048"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.033"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/nsr\/nwu038"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31354-7"},{"key":"e_1_2_12_14_1","volume-title":"CDC Health Information for International Travel 2014\u2010The Yellow Book","author":"Brunette Gary W","year":"2014"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12220"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2018.04.003"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22295"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-012-9411-2"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1086\/502978"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-398"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350901400216"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/135965350801300701"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(03)00002-4"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.129"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1114"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki273"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.04.024"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2018.04.004"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.04.002"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.20517\/2394\u20105079.2021.13"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.77"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13904"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028551"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.11.004"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2012.01602.x"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2015.06.140331"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03506.x"},{"key":"e_1_2_12_39_1","first-page":"1005","article-title":"Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon","volume":"49","author":"Kramata P","year":"1996","journal-title":"Mol Pharmacol"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00635-14"},{"key":"e_1_2_12_41_1","article-title":"Effects of antiviral therapy on the recurrence of hepatocellular carcinoma after curative resection or liver transplantation","volume":"12","author":"Yan D","year":"2012","journal-title":"Hepat Mon"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3865369"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.60.3.880-887.1986"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3252"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc864"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/26.1.205"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T07:07:22Z","timestamp":1700118442000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/jvh.13886"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13886","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,21]]},"assertion":[{"value":"2022-12-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}